Partnership merges glucose and biometric data to advance metabolic health insights.
A Strategic Collaboration
Dexcom has entered a $75 million partnership with Oura, integrating Dexcom’s glucose data with the Oura Ring’s vital sign, sleep, stress, and activity metrics. This collaboration aims to provide a more comprehensive view of users’ metabolic health.
Key Highlights:
- Dexcom’s glucose biosensors merge with Oura Ring biometrics for personalized health insights.
- Co-marketing and cross-selling of products to broaden user reach.
- Launch of app integrations planned for early 2025.
“Combining glucose data with Oura’s metrics allows users to better understand the connection between lifestyle choices and metabolic health,” said Matt Dolan, Dexcom’s EVP of strategy.
Redefining Health Monitoring
With more than 2.5 million rings sold and annual sales nearing $500 million, Oura introduces features like meal tracking, aligning with Dexcom’s mission to empower diabetes management.
Benefits of Integration:
- Personalized insights: Highlight links between diet, activity, and glucose levels.
- Behavioral guidance: Enable users to adjust sleep, exercise, and meal timing for improved health.
- Accessibility: Combines Dexcom’s OTC Stelo glucose sensor with the retail-available Oura Ring.
“This partnership empowers members to make informed decisions about their health,” said Tom Hale, CEO of Oura. “By correlating glucose levels with lifestyle metrics, we’re delivering actionable insights for long-term well-being.”
Pioneering Metabolic Health
Dexcom and Oura’s partnership represents a significant step forward in personalized health tracking, combining cutting-edge glucose monitoring with holistic biometric data to revolutionize metabolic care.
Follow MEDWIRE.AI for the latest developments in health technology collaborations transforming patient care.
